NutraLife BioSciences Statistics
Total Valuation
NutraLife BioSciences has a market cap or net worth of 18,061.
| Market Cap | 18,061 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NutraLife BioSciences has 180.61 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 180.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.64 |
| Interest Coverage | -1.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.48% |
| Return on Capital (ROIC) | -80.10% |
| Revenue Per Employee | 52,663 |
| Profits Per Employee | -332,510 |
| Employee Count | 12 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is -2.02, so NutraLife BioSciences's price volatility has been lower than the market average.
| Beta (5Y) | -2.02 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 34.37 |
| Average Volume (20 Days) | 34,340 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, NutraLife BioSciences had revenue of 631,957 and -3.99 million in losses. Loss per share was -0.02.
| Revenue | 631,957 |
| Gross Profit | 116,401 |
| Operating Income | -2.40M |
| Pretax Income | -3.99M |
| Net Income | -3.99M |
| EBITDA | -2.18M |
| EBIT | -2.40M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 431,713 in cash and 3.12 million in debt, giving a net cash position of -2.69 million or -0.01 per share.
| Cash & Cash Equivalents | 431,713 |
| Total Debt | 3.12M |
| Net Cash | -2.69M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.32M |
| Book Value Per Share | -0.01 |
| Working Capital | -3.58M |
Cash Flow
In the last 12 months, operating cash flow was -669,433 and capital expenditures -3,200, giving a free cash flow of -672,633.
| Operating Cash Flow | -669,433 |
| Capital Expenditures | -3,200 |
| Free Cash Flow | -672,633 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 18.42% |
| Operating Margin | -380.49% |
| Pretax Margin | -631.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -106.44% |
Dividends & Yields
NutraLife BioSciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.69% |
| Shareholder Yield | -8.69% |
| Earnings Yield | -23,019.00% |
| FCF Yield | -3,724.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NutraLife BioSciences has an Altman Z-Score of -12.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.7 |
| Piotroski F-Score | n/a |